AMNOG decision makers share new insights

On 18-19 April, The G-BA, Joint Arbitration Board and DAK have agreed to share never before seen insights into perfecting your AMNOG dossier. This will be exclusive for attendees of the International AMNOG summit, Berlin.

 

The program has been designed to give attendees intimate access to those who will determine whether pharma’s products succeed or fail in Germany.
 
With an agenda packed full of case studies and workshops, we have mapped out your route to achieving market access in Germany’s biggest market: eyeforpharma.com/amnog/agenda
 
Don’t miss your chance to see
  • Exclusive AMNOG success secrets revealed for the first time
  • Over 50 G-BA decisions deconstructed with the failure and success factors analysed
  • The Joint Arbitration Board, DAK and the G-BA share strategies for engagement 
There are only a few passes remaining, if you want to get ahead on AMNOG, register now: eyeforpharma.com/amnog/register
 
comments powered by Disqus